Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PREPROTO-M
- Development stage
- Unknown
- Lead developer
- RANTOMO Life Sciences Bharat
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
PREPROTO-M is an oral nutraceutical product developed and marketed by Rantomo Lifesciences, a pharmaceutical company based in Mumbai, India. It is formulated as a prebiotic and probiotic supplement designed to support digestive and gut health. While the specific microbial strains and prebiotic components are not explicitly detailed in the company's primary literature, the product name follows a common industry convention for 'Pre-Pro' (prebiotic and probiotic) combinations. Such formulations typically contain a blend of beneficial bacteria, such as *Lactobacillus* and *Bifidobacterium* species, alongside prebiotic fibers like fructooligosaccharides (FOS) to restore and maintain a healthy intestinal microbiome. It is marketed as a commercial product for general gut health maintenance and as a supportive therapy for gastrointestinal disturbances.
- Brand names
- PREPROTO-M
Beyond the preview
Go deeper on PREPROTO-M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PREPROTO-M.